Showing results (231-240 of 294) with videos related to

Sort By:
Pageof 30
Journal of Viral Hepatitis|September 29, 2009
Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatmentE Lukasiewicz, M Gorfine, L S Freedman, et al.
Journal of Viral Hepatitis|July 6, 2012
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapyM Biermer, B Schlosser, B Fülöp, et al.
Annals of Internal Medicine|October 17, 2001
Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancerJ Raedle, J Trojan, A Brieger, et al.
Journal of Chemotherapy (Florence, Italy)|June 23, 2010
Efficacy and safety of sorafenib in advanced hepatocellular carcinoma under daily practice conditionsM W Welker, N Lubomierski, C Gog, et al.
Gut|February 13, 2004
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivoA Stallmach, T Marth, B Weiss, et al.
Transplantation Proceedings|February 11, 2014
Improvement in gastrointestinal and health-related quality of life outcomes after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant recipientsM Sterneck, U Settmacher, T Ganten, et al.
International Journal of Colorectal Disease|February 24, 2007
Interleukin-18 is increased only in a minority of patients with active Crohn's diseaseC Schmidt, T Giese, R Goebel, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 20, 2007
[Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results]T J Vogl, S Zangos, J O Balzer, et al.
Journal of Crohn'S & Colitis|May 18, 2011
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based studyI Blumenstein, E Herrmann, N Filmann, et al.
Liver|February 13, 2001
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trialT Berg, R M Hoffmann, G Teuber, et al.
Pageof 30